Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
11m agoFatPipe Unveils VeloCloud Replacement Program with Price Match, 15% Discounts and 10% Partner Rebates
37m agoAngle Advisors announces Shift Transit has been recapitalized by Main Street Capital Corporation
38m agoCentury Complete Announces New Homes Coming Soon to Fleming Island, FL
38m agoSprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
39m agoTambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning
Ironwood Pharmaceuticals Inc logo

Ironwood Pharmaceuticals Inc

About

Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 23 2026
Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026
Feb 25 2026
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Results; Achieves 2025 Financial Guidance and Reiterates Strong 2026 Outlook
Feb 18 2026
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update Call
Jan 2 2026
Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance
Nov 10 2025
Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance

Financials

Revenue
$296.15 M
Market Cap
$577.23 M
P/E Ratio
23.60
EPS
0.15

Community Chat

Ask AI

6ix6ixAIEvents